OBJECTIVES: We evaluated changes in colorectal cancer (CRC) incidence and mortality by anatomic site to assess the possible impact of CRC screening. METHODS: Using data from 9 Surveillance, Epidemiology, and End Results cancer registries, we estimated trends in 1975-2007 CRC incidence and 1985-2007 incidence-based mortality. We evaluated trends separately for proximal and distal CRC, overall and by stage, tumor site, and race. RESULTS: Between 1975 and 2007, 323 237 adults in the study area were diagnosed with CRC. For most tumor and population subgroups, incidence rates increased between 1975 and 1985 and subsequently declined markedly. Declines were most rapid between 1999 and 2007 and were greater for distal than proximal CRC. Declines in incidence were greater for White than Black adults and greatest for regional-stage disease. There was little difference in trends across subsites within the proximal and distal colorectum. Declines in incidence-based mortality mirrored those for incidence. CONCLUSIONS: Recent declines in CRC incidence and mortality are greater for distal than proximal CRC. Differing trends across populations may reflect variations in screening prevalence; distinct trends by tumor characteristics likely reflect differences in screening efficacy.
OBJECTIVES: We evaluated changes in colorectal cancer (CRC) incidence and mortality by anatomic site to assess the possible impact of CRC screening. METHODS: Using data from 9 Surveillance, Epidemiology, and End Results cancer registries, we estimated trends in 1975-2007 CRC incidence and 1985-2007 incidence-based mortality. We evaluated trends separately for proximal and distal CRC, overall and by stage, tumor site, and race. RESULTS: Between 1975 and 2007, 323 237 adults in the study area were diagnosed with CRC. For most tumor and population subgroups, incidence rates increased between 1975 and 1985 and subsequently declined markedly. Declines were most rapid between 1999 and 2007 and were greater for distal than proximal CRC. Declines in incidence were greater for White than Black adults and greatest for regional-stage disease. There was little difference in trends across subsites within the proximal and distal colorectum. Declines in incidence-based mortality mirrored those for incidence. CONCLUSIONS: Recent declines in CRC incidence and mortality are greater for distal than proximal CRC. Differing trends across populations may reflect variations in screening prevalence; distinct trends by tumor characteristics likely reflect differences in screening efficacy.
Authors: Robert A Smith; Vilma Cokkinides; Durado Brooks; Debbie Saslow; Mona Shah; Otis W Brawley Journal: CA Cancer J Clin Date: 2011-01-04 Impact factor: 508.702
Authors: Ben Yan; Anne-Michelle Noone; Cecilia Yee; Mousumi Banerjee; Kendra Schwartz; Michael S Simon Journal: Cancer Date: 2009-08-15 Impact factor: 6.860
Authors: Nancy N Baxter; Meredith A Goldwasser; Lawrence F Paszat; Refik Saskin; David R Urbach; Linda Rabeneck Journal: Ann Intern Med Date: 2008-12-15 Impact factor: 25.391
Authors: D Heresbach; T Barrioz; M G Lapalus; D Coumaros; P Bauret; P Potier; D Sautereau; C Boustière; J C Grimaud; C Barthélémy; J Sée; I Serraj; P N D'Halluin; B Branger; T Ponchon Journal: Endoscopy Date: 2008-04 Impact factor: 10.093
Authors: Jean A Shapiro; Laura C Seeff; Trevor D Thompson; Marion R Nadel; Carrie N Klabunde; Sally W Vernon Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-07 Impact factor: 4.254
Authors: Bernard Levin; David A Lieberman; Beth McFarland; Robert A Smith; Durado Brooks; Kimberly S Andrews; Chiranjeev Dash; Francis M Giardiello; Seth Glick; Theodore R Levin; Perry Pickhardt; Douglas K Rex; Alan Thorson; Sidney J Winawer Journal: CA Cancer J Clin Date: 2008-03-05 Impact factor: 508.702
Authors: Amanda I Phipps; Michael N Passarelli; Andrew T Chan; Tabitha A Harrison; Jihyoun Jeon; Carolyn M Hutter; Sonja I Berndt; Hermann Brenner; Bette J Caan; Peter T Campbell; Jenny Chang-Claude; Stephen J Chanock; Jeremy P Cheadle; Keith R Curtis; David Duggan; David Fisher; Charles S Fuchs; Manish Gala; Edward L Giovannucci; Richard B Hayes; Michael Hoffmeister; Li Hsu; Eric J Jacobs; Lina Jansen; Richard Kaplan; Elisabeth J Kap; Timothy S Maughan; John D Potter; Robert E Schoen; Daniela Seminara; Martha L Slattery; Hannah West; Emily White; Ulrike Peters; Polly A Newcomb Journal: Carcinogenesis Date: 2015-11-19 Impact factor: 4.944
Authors: Nadia Howlader; Lindsay M Morton; Eric J Feuer; Caroline Besson; Eric A Engels Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-10-15 Impact factor: 4.254
Authors: Vivien W Chen; Mei-Chin Hsieh; Mary E Charlton; Bernardo A Ruiz; Jordan Karlitz; Sean F Altekruse; Lynn A G Ries; J Milburn Jessup Journal: Cancer Date: 2014-12-01 Impact factor: 6.860
Authors: Norah Alsadhan; Alaa Almaiman; Mar Pujades-Rodriguez; Cathy Brennan; Farag Shuweihdi; Sultana A Alhurishi; Robert M West Journal: BMC Med Res Methodol Date: 2022-05-19 Impact factor: 4.612
Authors: Amanda I Phipps; Qian Shi; Paul J Limburg; Garth D Nelson; Daniel J Sargent; Frank A Sinicrope; Emily Chan; Sharlene Gill; Richard M Goldberg; Morton Kahlenberg; Suresh Nair; Anthony F Shields; Polly A Newcomb; Steven R Alberts Journal: Int J Cancer Date: 2016-05-09 Impact factor: 7.396
Authors: Lawrence F Paszat; Rinku Sutradhar; Elyse Corn; Jill Tinmouth; Nancy N Baxter; Linda Rabeneck Journal: J Can Assoc Gastroenterol Date: 2020-10-15